Literature DB >> 10330185

Fli-1, an Ets-related transcription factor, regulates erythropoietin-induced erythroid proliferation and differentiation: evidence for direct transcriptional repression of the Rb gene during differentiation.

A Tamir1, J Howard, R R Higgins, Y J Li, L Berger, E Zacksenhaus, M Reis, Y Ben-David.   

Abstract

Erythropoietin (Epo) is a major regulator of erythropoiesis that alters the survival, proliferation, and differentiation of erythroid progenitor cells. The mechanism by which these events are regulated has not yet been determined. Using HB60, a newly established erythroblastic cell line, we show here that Epo-induced terminal erythroid differentiation is associated with a transient downregulation in the expression of the Ets-related transcription factor Fli-1. Constitutive expression of Fli-1 in HB60 cells, similar to retroviral insertional activation of Fli-1 observed in Friend murine leukemia virus (F-MuLV)-induced erythroleukemia, blocks Epo-induced differentiation while promoting Epo-induced proliferation. These results suggest that Fli-1 modulates the response of erythroid cells to Epo. To understand the mechanism by which Fli-1 regulates erythropoiesis, we searched for downstream target genes whose expression is regulated by this transcription factor. Here we show that the retinoblastoma (Rb) gene, which was previously shown to be involved in the development of mature erythrocytes, contains a Fli-1 consensus binding site within its promoter. Fli-1 binds to this cryptic Ets consensus site within the Rb promoter and transcriptionally represses Rb expression. Both the expression level and the phosphorylation status of Rb are consistent with the response of HB60 cells to Epo-induced terminal differentiation. We suggest that the negative regulation of Rb by Fli-1 could be one of the critical determinants in erythroid progenitor cell differentiation that is specifically deregulated during F-MuLV-induced erythroleukemia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10330185      PMCID: PMC104404          DOI: 10.1128/MCB.19.6.4452

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  78 in total

Review 1.  Structure, function, and activation of the erythropoietin receptor.

Authors:  H Youssoufian; G Longmore; D Neumann; A Yoshimura; H F Lodish
Journal:  Blood       Date:  1993-05-01       Impact factor: 22.113

2.  Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation.

Authors:  W A May; M L Gishizky; S L Lessnick; L B Lunsford; B C Lewis; O Delattre; J Zucman; G Thomas; C T Denny
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

3.  The retinoblastoma binding factor 1 (RBF-1) site in RB gene promoter binds preferentially E4TF1, a member of the Ets transcription factors family.

Authors:  E Savoysky; T Mizuno; Y Sowa; H Watanabe; J Sawada; H Nomura; Y Ohsugi; H Handa; T Sakai
Journal:  Oncogene       Date:  1994-07       Impact factor: 9.867

4.  Molecular cloning and characterization of the mouse RB1 promoter.

Authors:  E Zacksenhaus; R M Gill; R A Phillips; B L Gallie
Journal:  Oncogene       Date:  1993-09       Impact factor: 9.867

5.  Analysis of the DNA-binding and transcriptional activation functions of human Fli-1 protein.

Authors:  V N Rao; T Ohno; D D Prasad; G Bhattacharya; E S Reddy
Journal:  Oncogene       Date:  1993-08       Impact factor: 9.867

6.  The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB.

Authors:  C Hagemeier; A J Bannister; A Cook; T Kouzarides
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

7.  Temporal order and functional analysis of mutations within the Fli-1 and p53 genes during the erythroleukemias induced by F-MuLV.

Authors:  J C Howard; S Yousefi; G Cheong; A Bernstein; Y Ben-David
Journal:  Oncogene       Date:  1993-10       Impact factor: 9.867

8.  Erythropoietin receptor signals both proliferation and erythroid-specific differentiation.

Authors:  E Liboi; M Carroll; A D D'Andrea; B Mathey-Prevot
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

9.  Mapping Polycomb-repressed domains in the bithorax complex using in vivo formaldehyde cross-linked chromatin.

Authors:  V Orlando; R Paro
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

10.  The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members.

Authors:  L Zhang; V Lemarchandel; P H Romeo; Y Ben-David; P Greer; A Bernstein
Journal:  Oncogene       Date:  1993-06       Impact factor: 9.867

View more
  35 in total

1.  Direct regulation of BCL-2 by FLI-1 is involved in the survival of FLI-1-transformed erythroblasts.

Authors:  Isabelle Lesault; Christine Tran Quang; Jon Frampton; Jacques Ghysdael
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

Review 2.  Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis.

Authors:  Natasza A Kurpios; Nancy A Sabolic; Trevor G Shepherd; Gina M Fidalgo; John A Hassell
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

3.  Functional cross-antagonism between transcription factors FLI-1 and EKLF.

Authors:  Joëlle Starck; Nathalie Cohet; Colette Gonnet; Sandrine Sarrazin; Zina Doubeikovskaia; Alexandre Doubeikovski; Alexis Verger; Martine Duterque-Coquillaud; François Morle
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

4.  Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene.

Authors:  Jianjun Zhang; Haiyan Guo; He Zhang; Haibo Wang; Guanxiang Qian; Xianqun Fan; Andrew R Hoffman; Ji-Fan Hu; Shengfang Ge
Journal:  Cancer       Date:  2010-08-24       Impact factor: 6.860

5.  Enhanced natural-killer cell and erythropoietic activities in VEGF-A-overexpressing mice delay F-MuLV-induced erythroleukemia.

Authors:  David Cervi; Yuval Shaked; Mehran Haeri; Tatiana Usenko; Christina R Lee; Jody J Haigh; Andras Nagy; Robert S Kerbel; Eitan Yefenof; Yaacov Ben-David
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

6.  Downregulation of Friend leukemia virus integration 1 as a feedback mechanism that restrains lipopolysaccharide induction of matrix metalloproteases and interleukin-10 in human macrophages.

Authors:  Hao H Ho; Lionel B Ivashkiv
Journal:  J Interferon Cytokine Res       Date:  2010-09-29       Impact factor: 2.607

Review 7.  Molecular mechanisms of ETS transcription factor-mediated tumorigenesis.

Authors:  Adwitiya Kar; Arthur Gutierrez-Hartmann
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-09-25       Impact factor: 8.250

8.  Specificity Protein 7 Is Required for Proliferation and Differentiation of Ameloblasts and Odontoblasts.

Authors:  Ji-Myung Bae; John C Clarke; Harunur Rashid; Mitra D Adhami; Kayla McCullough; Jordan S Scott; Haiyan Chen; Krishna M Sinha; Benoit de Crombrugghe; Amjad Javed
Journal:  J Bone Miner Res       Date:  2018-03-24       Impact factor: 6.741

9.  PDEF is a negative regulator of colon cancer cell growth and migration.

Authors:  Omar Moussa; David P Turner; Ron J Feldman; Victor I Sementchenko; Brent D McCarragher; Mohamed M Desouki; Mostafa Fraig; Dennis K Watson
Journal:  J Cell Biochem       Date:  2009-12-15       Impact factor: 4.429

10.  Spi-1 and Fli-1 directly activate common target genes involved in ribosome biogenesis in Friend erythroleukemic cells.

Authors:  Gaëtan Juban; Guillaume Giraud; Boris Guyot; Stéphane Belin; Jean-Jacques Diaz; Joëlle Starck; Christel Guillouf; Françoise Moreau-Gachelin; François Morlé
Journal:  Mol Cell Biol       Date:  2009-03-16       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.